Getting Everyone on Board to Break the Cycle of Bacterial Vaginosis (BV) Recurrence: A Qualitative Study of Partner Treatment for BV.

Introduction: Bacterial vaginosis (BV) is a common condition that affects the sexual wellbeing of women and other people with a vagina. Recurrence following individual treatment is frequent and exerts a cumulative burden over time. Researchers at the Melbourne Sexual Health Center have recently completed the first successful trial of male partner treatment (MPT) for BV, demonstrating the superior effectiveness of concurrent MPT in reducing recurrence.

Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis.

Background: Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis-associated organisms between partners suggests that male-partner treatment may increase the likelihood of cure.

Methods: This open-label, randomized, controlled trial involved couples in which a woman had bacterial vaginosis and was in a monogamous relationship with a male partner.

Diversity of Mycoplasma genitalium strains in Australia: relationship with sexual networks and antimicrobial resistance.

Purpose: Molecular typing can identify relationships between M. genitalium strains and antimicrobial resistance and demographic data. We examined the association of mgpB sequence types (STs) with sex/sexual orientation, antimicrobial resistance and geographical location for M.

Trends in infections detected in women with cervicitis over a decade.

Objectives: There is a growing body of evidence that in the absence of and/or and bacterial vaginosis (BV) are associated with cervicitis. We aimed to describe infections detected among cervicitis cases over a decade and establish how commonly and BV were detected among non-chlamydial/non-gonococcal cases to inform testing and treatment practices.

Methods: We conducted a retrospective case-series to determine the number of cervicitis cases diagnosed with genital infections (, and BV) among women attending the largest public sexual health service in Australia from 2011 to 2021.